Yafang Tu

Dr. Yafang Tu

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2019 in BMC Immunology
Verified
Journal Article
Open access
PDF file
YTYafang Tu
Yafang Tu
XWXiongfei Wu
Xiongfei Wu
FYFengyun Yu
Fengyun Yu
JDJianzhong Dang
Jianzhong Dang
JWJuan Wang
Juan Wang
YZYi Zhang
Yi Zhang
Tristetraprolin (TTP) is an RNA binding protein that plays a critical role in regulating proinflammatory immune responses by destabilizing target mRNAs via binding to their AU-rich elements (AREs) in the 3′-UTRs of mRNAs. A recent CLIP-seq study revealed that TTP-binding sites are enriched in the intronic regions of RNA. TTP is also a nuclear protein that exhibits putative DNA-binding activity. These features suggested that TTP might regulate gene transcription and/or alternative splicing of pre-mRNAs in the absence of stimulation. To elucidate the regulatory pattern of TTP, we cloned and overexpressed the human TTP-encoding gene, ZFP36, in HeLa cells in the absence of inflammatory stimuli. The transcriptomes of the control and ZFP36-overexpressing cells were sequenced and subjected to analysis and validation. Upon ZFP36 overexpression, the expression of genes associated with innate immunity, including those in the type I interferon signaling pathway and viral response, were specifically upregulated, implying a transcriptional regulatory mechanism associated with the predicted DNA binding activity of TTP. TTP preferentially regulated the alternative splicing of genes involved in the positive regulation of the I-κB/NF-κB cascade and the TRIF-dependent toll-like receptor, MAPK, TNF, and T cell receptor signaling pathways. Our findings indicated that TTP may regulate the immune response via the regulation of alternative splicing and potentially transcription, which greatly expands the current understanding of the mechanisms of TTP-mediated gene regulation.

1 May 2020 in Molecular Immunology
Verified
Journal Article
Closed access
YTYafang Tu
Yafang Tu
XWXiongfei Wu
Xiongfei Wu
FYFengyun Yu
Fengyun Yu
JDJianzhong Dang
Jianzhong Dang
YWYaxun Wei
Yaxun Wei
JWJuan Wang
Juan Wang

13 July 2023 in Research Square
Verified
Preprint
Open access
PDF file
JWJuan Wang
Juan Wang
WLWenliang Liao
Wenliang Liao
WQWeili Quan
Weili Quan
SCShengguo Cao
Shengguo Cao
YTYafang Tu
Yafang Tu
Understanding the mechanisms mediating secondary nonimmune renal injury in lupus nephritis (LN) is important for therapeutic development. Cytotoxic granule-associated RNA-binding protein 1 (T-cell-resrticted intracellular antigen 1, TIA1) plays potential roles in infiltrating immune cells in LN. However, the regulatory targets and mechanisms underlying TIA1 activity in renal nonimmune cells remain unclear. Here, TIA1 was overexpressed in a human renal tubular epithelial cell line (HK-2). Then, RNA sequencing and bioinformatic analysis were performed to compare the expression profile and alternative splicing pattern in TIA1-overexpressing (TIA1-OE) and control cells. Additionally, the expression of Tia1 and the genes that it may regulate in the kidney tissues of LN mice was analysed. The results showed TIA1-OE increased and decreased the transcript levels of 101 and 452 genes in HK-2 cells, respectively. Gene Ontology (GO)analysis showed that the downregulated genes were significantly enriched in several terms associated with the cellular response to stress. Moreover, TIA1-OE changed the pattern of 2,035 alternative splicing events that occurred in 1,420 genes in HK-2 cells. GO analysis showed t genes were significantly enriched in DNA repair and cellular response to DNA damage stimulus terms. These results demonstrate that TIA1 mediates secondary nonimmune renal injury by regulating the expression and alternative splicing of stress-related genes in renal tubular epithelial cells, which provides a reference for targeted therapy for renal injury in LN.